Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...

The company's multibillion-dollar investments in manufacturing in the U.S. are likely to be warmly welcomed by the Trump administration. Eli Lilly's management has already committed to taking action ...

Most effective drugs for obesity and its complications are semaglutide, tirzepatide, new European guideline says Certain GLP-1 drugs are best for specific complications The non-binding guideline ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...

Eli Lilly & Co. halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons it didn’t disclose. Lilly closed the trial on ...

EVANGELINE PARISH, La (KLFY) — Evangeline Parish is set to open a new multimillion-dollar jail facility which will significantly expand its inmate capacity. The new jail, currently under construction, ...

Shooting 96 episodes in 90 days was never a recipe for success, the YouTube star said on 'The Julia Cunningham Show.' By Etan Vlessing Canada Bureau Chief “I don’t want to say you were set up to fail.

IMDb.com, Inc. n'assume aucune responsabilité quant au contenu ou à l'exactitude des articles de presse, des tweets ou des billets de blogue susmentionnés. Ce contenu est publié uniquement dans le but ...

IMDb.com, Inc. übernimmt keine Verantwortung für den Inhalt oder die Richtigkeit der oben genannten Nachrichtenartikel, Tweets oder Blog-Beiträge. Dieser Inhalt wird nur zur Unterhaltung unserer ...

Evangeline Lilly's pregnancy has prevented her from wearing her Wasp superhero suit. The 35-year-old actress showed the world her baby bump for the first time in June at the premiere of the 'Ant-Man' ...

Eli Lilly is making waves in the corporate debt market with a $6.75 billion multi-tranche bond sale that includes a rare 40-year note: an unusual move for a pharmaceutical company. Most corporate ...